Issue 144 • July 2024

UK’s new Netflix-style funding model for antibiotics goes live

The UK NHS has become the first system to permanently adopt a subscription payment model for new antibiotics.

Briefing

Genmab acquires biotechnology company ProfoundBio in $1.8bn deal

Feature

Swiss biotech ecosystem recuperates from global financial instability

Feature

Can supermarket pharmacies plug urgent healthcare gaps?

Comment

Moderna/MSD’s cancer vaccine may transform melanoma landscape

Go to article: Home | UK’s new Netflix-style funding model for antibiotics goes liveGo to article: Editor's letterGo to article: ContentsGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: NiproGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article: Trends & InsightGo to article: Körber Company InsightGo to article: KörberGo to article: In DepthGo to article: UK’s new Netflix-style funding model for antibiotics goes liveGo to article: Swiss biotech ecosystem recuperates from global financial instabilityGo to article: Can supermarket pharmacies plug urgent healthcare gaps?Go to article: Will WHO’s new guidance spur hepatitis B immunisation?Go to article: ASCO24: Moderna/MSD’s cancer vaccine may transform melanoma landscapeGo to article: How patient advocacy can lead to more successful and meaningful clinical trialsGo to article: Sponsored SupplementsGo to article: Lactalis IngredientsGo to article: Avenga Company InsightGo to article: ListingsGo to article: EventsGo to article: Excellence AwardsGo to article: Innovation RankingsGo to article: Buyer's GuidesGo to article: Next issue